King-Jones Heidy
Insider CIK 1794898 · AXLA General Counsel, SVP Legal · SYRE See Remarks · PRVB Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-02 | 28,933 | — | $0 | 482,478 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 2,600 | $93.46 | $243.0K | 2,845 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 2,100 | $92.70 | $194.7K | 5,445 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 7,228 | $91.35 | $660.3K | 7,545 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 16,605 | $90.35 | $1.50M | 14,773 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 400 | $89.24 | $35.7K | 31,378 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-10-01 | 2026-10-02 | 28,933 | $14.50 | $419.5K | 31,778 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-09-02 | 2026-09-03 | 400 | — | $0 | 511,411 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-09-02 | 2026-09-03 | 400 | $14.50 | $5.8K | 3,245 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 400 | $90.00 | $36.0K | 2,845 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-09-02 | 2026-09-03 | 400 | — | $0 | 511,411 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 400 | $90.00 | $36.0K | 2,845 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-09-02 | 2026-09-03 | 400 | $14.50 | $5.8K | 3,245 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 27,999 | — | $0 | 511,811 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 400 | $89.38 | $35.8K | 2,845 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 6,206 | $88.17 | $547.2K | 3,245 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 16,548 | $87.20 | $1.44M | 9,451 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 4,845 | $86.40 | $418.6K | 25,999 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 27,999 | $14.50 | $406.0K | 30,844 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 27,999 | — | $0 | 511,811 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 400 | $89.38 | $35.8K | 2,845 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 6,206 | $88.17 | $547.2K | 3,245 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 16,548 | $87.20 | $1.44M | 9,451 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 4,845 | $86.40 | $418.6K | 25,999 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 27,999 | $14.50 | $406.0K | 30,844 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2026-01-09 | 2026-01-13 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 95,500 | — | $0 | 95,500 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-02 | 63,000 | — | $0 | 63,000 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2023-09-01 | 2023-09-05 | 13,495,255 | — | $0 | 13,495,255 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 300,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 200,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 145,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 139,500 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2023-01-10 | 2023-01-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-11-22 | 2022-11-23 | 90,000 | — | $0 | 300,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-03-22 | 2022-03-24 | 60,000 | — | $0 | 210,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 30,000 | — | $0 | 150,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2020-08-03 | 2020-08-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| AXLA Axcella Health Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 35,000 | — | $0 | 35,000 | SEC↗ |